HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications (Q35835143)

10 August 2017

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications (English)

1 reference

10 August 2017

D C Rijkaart

1

1 reference

10 August 2017

J Berkhof

2

1 reference

10 August 2017

F J van Kemenade

3

1 reference

10 August 2017

V M H Coupe

4

1 reference

10 August 2017

L Rozendaal

5

1 reference

10 August 2017

D A M Heideman

6

1 reference

10 August 2017

R H M Verheijen

7

1 reference

10 August 2017

S Bulk

8

1 reference

10 August 2017

W Verweij

9

1 reference

10 August 2017

P J F Snijders

10

1 reference

10 August 2017

C J L M Meijer

11

1 reference

10 August 2017

language of work or name

English

0 references

publication date

17 January 2012

1 reference

British Journal of Cancer

10 August 2017

1 reference

10 August 2017

106

1 reference

10 August 2017

5

1 reference

10 August 2017

975-981

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2011.581

10 August 2017

0 references

cites work

Trends of cervical cancer mortality in the member states of the European Union

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Risk assessment to guide the prevention of cervical cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study).

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

One-sided confidence intervals in discrete distributions

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.581

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.581

Is the UK ready to embrace HPV testing?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.581

HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305964

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

15 November 2018

1 reference

12 December 2020

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

12 December 2020

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

1 reference

12 December 2020

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

1 reference

12 December 2020

High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy

1 reference

12 December 2020

Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies

1 reference

12 December 2020

Criteria for organized cervical screening programs. Special emphasis on The Netherlands program

1 reference

12 December 2020

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial

1 reference

12 December 2020

Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2011.581

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference